Health-related quality of life of multisystem atrophy and progressive supranuclear palsy patients
Objective: The aim of our study was to describe how different aspects of daily living and health related quality of life (HRQoL) are impaired by…Pan American multiple system atrophy (PANMSA) consortium database
Objective: To create a database coordinating individual MSA study groups of the Pan American region with the required standards by the Global MSA Registry, as…"Atypical" atypical parkinsonism
Objective: To look for additional “atypical“ features in a cohort of patients with a referring diagnosis of a certain atypical parkinsonism using the current diagnostic…Cognitive profile in the Parkinsonian variant of multiple system atrophy: Findings from a Tunisian cohort
Objective: To establish the cognitive profile of MSA-P in a Tunisian cohort and to discuss its association with motor signs. Background: It has been previously…Multiple system atrophy: A comparison between clinical subtypes
Objective: To evaluate the cognitive impairment and sleep disturbances in subtype MSA-P versus MSA-C. Background: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder of…A cross-sectional study of sensor-based gait analysis in atypical Parkinsonian disorders
Objective: Primary objective was to identify quantitative markers of gait impairment in patients with idiopathic Parkinson's disease (IPD), atypical Parkinsonian disorders (APD) and healthy controls…Dat-SPECT in multiple system atrophy (MSA)
Objective: To evaluate the extent of degeneration in dopamine nerve terminal in striatum with the patients with MSA, and compared between subtypes and disease duration…MRI-supported diagnosis of multiple system atrophy: Implications for clinical trials
Objective: To assess whether MSA-specific MRI changes predict a more rapid clinical decline in a cohort of patients with a clinical diagnosis of MSA. Background:…PROSPECT: A UK-based longitudinal observational study of PSP, CBD, MSA and atypical parkinsonism syndromes
Objective: To aid the development of curative treatments, we need to develop better methods for diagnosing Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) and Multiple…Oxysterol and chitotriosidase as biomarkers for atypical Parkinsonian symptoms?
Objective: The aim of the study is to establish chitotriosidase and oxysterols as a biomarker for atypical Parkinsonian syndromes in order to make a distinction…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.